177 related articles for article (PubMed ID: 21156459)
1. A decade of progress in lymphoma: advances and continuing challenges.
Flowers CR; Armitage JO
Clin Lymphoma Myeloma Leuk; 2010 Dec; 10(6):414-23. PubMed ID: 21156459
[TBL] [Abstract][Full Text] [Related]
2. Transformative Clinical Trials in Non-Hodgkin and Hodgkin Lymphomas.
Abramson JS
Clin Lymphoma Myeloma Leuk; 2015 Jun; 15 Suppl():S141-6. PubMed ID: 26297267
[TBL] [Abstract][Full Text] [Related]
3. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
4. Non-Hodgkin lymphoma: diagnosis and treatment.
Ansell SM; Armitage J
Mayo Clin Proc; 2005 Aug; 80(8):1087-97. PubMed ID: 16092591
[TBL] [Abstract][Full Text] [Related]
5. [Recent progress in the treatment of malignant lymphoma].
Ogura M
Gan To Kagaku Ryoho; 2001 Sep; 28(9):1213-35. PubMed ID: 11579632
[TBL] [Abstract][Full Text] [Related]
6. New therapies in non-Hodgkin lymphoma.
Novelli S; Sierra J; Briones J
Expert Rev Anticancer Ther; 2015 Mar; 15(3):349-59. PubMed ID: 25582186
[TBL] [Abstract][Full Text] [Related]
7. CD20-positive plasmablastic lymphoma with excellent response to bortezomib combined with rituximab.
Yan M; Dong Z; Zhao F; Chauncey T; Deauna-Limayo D; Wang-Rodriguez J; Liu D; Wang HY; Pilz R
Eur J Haematol; 2014 Jul; 93(1):77-80. PubMed ID: 24528507
[TBL] [Abstract][Full Text] [Related]
8. Development of targeted therapies for B-cell non-Hodgkin lymphoma and multiple myeloma.
Hernandez-Ilizaliturri FJ; Gowda A; Czuczman MS
Clin Adv Hematol Oncol; 2004 Sep; 2(9):606-18. PubMed ID: 16163245
[TBL] [Abstract][Full Text] [Related]
9. Transformed non-Hodgkin lymphoma in the rituximab era: analysis of the NCCN outcomes database.
Ban-Hoefen M; Vanderplas A; Crosby-Thompson AL; Abel GA; Czuczman MS; Gordon LI; Kaminski MS; Kelly J; Millenson M; Nademanee AP; Rodriguez MA; Zelenetz AD; Niland J; LaCasce AS; Friedberg JW
Br J Haematol; 2013 Nov; 163(4):487-95. PubMed ID: 24111533
[TBL] [Abstract][Full Text] [Related]
10. Lymphoma 2006: classification and treatment.
Armitage JO; Bierman PJ; Bociek RG; Vose JM
Oncology (Williston Park); 2006 Mar; 20(3):231-9; discussion 242, 244, 249. PubMed ID: 16629256
[TBL] [Abstract][Full Text] [Related]
11. Improved survival with rituximab-based chemoimmunotherapy in older patients with extranodal diffuse large B-cell lymphoma.
Olszewski AJ; Winer ES; Castillo JJ
Leuk Res; 2014 Aug; 38(8):866-73. PubMed ID: 24837081
[TBL] [Abstract][Full Text] [Related]
12. Bendamustine with or without rituximab for the treatment of heavily pretreated non-Hodgkin's lymphoma patients : A multicenter retrospective study on behalf of the Italian Lymphoma Foundation (FIL).
Rigacci L; Puccini B; Cortelazzo S; Gaidano G; Piccin A; D'Arco A; Freilone R; Storti S; Orciuolo E; Zinzani PL; Zaja F; Bongarzoni V; Balzarotti M; Rota-Scalabrini D; Patti C; Gobbi M; Carpaneto A; Liberati AM; Bosi A; Iannitto E
Ann Hematol; 2012 Jul; 91(7):1013-22. PubMed ID: 22349722
[TBL] [Abstract][Full Text] [Related]
13. [Retrospective survey on the clinical features of non-Hodgkin lymphomas in Gunma Prefecture, Japan].
Hashimoto Y; Yokohama A; Saitoh A; Nakahashi H; Toyama K; Mitsui T; Koiso H; Saitoh T; Handa H; Uchiumi H; Jinbo T; Murayama K; Tamaki Y; Matsumoto M; Sawamura M; Karasawa M; Murakami H; Hirato J; Nojima Y; Kojima M; Tsukamoto N
Rinsho Ketsueki; 2012 Mar; 53(3):329-36. PubMed ID: 22499050
[TBL] [Abstract][Full Text] [Related]
14. Ifosfamide, etoposide, cytarabine, and dexamethasone as salvage treatment followed by high-dose cyclophosphamide, melphalan, and etoposide with autologous peripheral blood stem cell transplantation for relapsed or refractory lymphomas.
Schütt P; Passon J; Ebeling P; Welt A; Müller S; Metz K; Moritz T; Seeber S; Nowrousian MR
Eur J Haematol; 2007 Feb; 78(2):93-101. PubMed ID: 17313557
[TBL] [Abstract][Full Text] [Related]
15. Non-Hodgkin lymphoma: an update.
Hennessy BT; Hanrahan EO; Daly PA
Lancet Oncol; 2004 Jun; 5(6):341-53. PubMed ID: 15172354
[TBL] [Abstract][Full Text] [Related]
16. [Non-Hodgkin's lymphoma: treatment and outcome of children with advanced disease].
Tsurusawa M
Gan To Kagaku Ryoho; 1999 Jul; 26(8):1050-5. PubMed ID: 10431576
[TBL] [Abstract][Full Text] [Related]
17. Perspectives of the management of childhood lymphoma: experience at Tygerberg Hospital, Western Cape, South Africa.
Wessels G; Bernard Hesseling P
Transfus Apher Sci; 2005 Feb; 32(1):27-31. PubMed ID: 15737871
[TBL] [Abstract][Full Text] [Related]
18. [Treatment options in non-Hodgkin lymphomas].
Tilly H
Rev Prat; 2010 Jan; 60(1):69-74. PubMed ID: 20222315
[TBL] [Abstract][Full Text] [Related]
19. Improving outcomes for patients with diffuse large B-cell lymphoma.
Flowers CR; Sinha R; Vose JM
CA Cancer J Clin; 2010; 60(6):393-408. PubMed ID: 21030533
[TBL] [Abstract][Full Text] [Related]
20. Impact of prior rituximab on outcomes of autologous stem-cell transplantation in patients with relapsed or refractory aggressive B-cell lymphoma: a multicentre retrospective Spanish group of lymphoma/autologous bone marrow transplant study.
Redondo AM; Pomares H; Vidal MJ; Pascual MJ; Quereda B; Sancho JM; Polo M; López J; Conde E; Jarque I; Alonso N; Ramírez MJ; Fernández P; Sayas MJ; Requena MJ; Salar A; González JD; González-Barca E; Arranz R; Caballero D; Martín A
Br J Haematol; 2014 Mar; 164(5):668-74. PubMed ID: 24274082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
